Royal Bank of Canada’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-40
| Closed | -$2K | – | 6627 |
|
|
2025
Q1 | $2K | Buy |
+40
| New | +$2K | ﹤0.01% | 6163 |
|
|
2024
Q1 | – | Sell |
-100
| Closed | -$6K | – | 6542 |
|
|
2023
Q4 | $6K | Buy |
+100
| New | +$6K | ﹤0.01% | 6067 |
|
|
2021
Q1 | – | Sell |
-200
| Closed | -$17K | – | 6893 |
|
|
2020
Q4 | $17K | Hold |
200
| – | – | ﹤0.01% | 5576 |
|
|
2020
Q3 | $14K | Buy |
+200
| New | +$14K | ﹤0.01% | 5325 |
|
|
2019
Q3 | – | Sell |
-800
| Closed | -$41K | – | 5981 |
|
|
2019
Q2 | $41K | Buy |
+800
| New | +$41K | ﹤0.01% | 4674 |
|
|
2016
Q1 | – | Sell |
-180
| Closed | -$13K | – | 5607 |
|
|
2015
Q4 | $13K | Buy |
180
+110
| +157% | +$7.94K | ﹤0.01% | 5111 |
|
|
2015
Q3 | $4K | Buy |
+70
| New | +$4K | ﹤0.01% | 5612 |
|
|
2015
Q1 | – | Sell |
-100
| Closed | -$13K | – | 5650 |
|
|
2014
Q4 | $13K | Sell |
100
-100
| -50% | -$13K | ﹤0.01% | 4938 |
|
|
2014
Q3 | $21K | Buy |
+200
| New | +$21K | ﹤0.01% | 4719 |
|